使用组配式非骨水泥股骨柄行髋关节翻修术:长期随访
单中心回顾性分析2002年1月至2007年10月使用非骨水泥组配式股骨柄行髋关节翻修术的患者,84例(89髋)中位年龄69岁,翻修指征包括无菌性松动(84.2%)、感染(12.4%)和假体周围骨折(3.4%);至少14年随访时患者报告结局评分显著改善,组配式非骨水泥翻修柄显示出长期临床成功,仍是复杂翻修手术安全可靠的选择。
要点
- 84例(89髋)使用非骨水泥组配式股骨柄行翻修髋关节置换术,中位年龄69岁。
- 22髋发生至少1种并发症,包括术中骨折7.9%、脱位6.7%、假体周围感染4.5%等。
- 至少14年随访时UCLA活动、VR-12生理、HOOS-JR和Harris髋关节评分疼痛与功能均显著改善。
核心结论
- 非骨水泥组配式翻修柄显示出长期临床成功,仍是复杂翻修手术安全可靠的选择。
- 长期随访的挑战包括患者迁移、不愿长途旅行复查、合并症、高龄和死亡。
研究设计与样本
- 回顾性综述,纳入2002年1月至2007年10月在同一机构使用非骨水泥组配式柄行翻修全髋关节置换术的患者。
- 共纳入84例患者(89髋),手术时中位年龄69岁(范围28至88岁)。
- 收集患者人口学、临床和影像学数据,比较术前与术后至少14年随访时的患者报告结局评分。
主要发现
- 翻修指征包括无菌性松动(84.2%)、感染(12.4%)和假体周围骨折(3.4%)。
- 22髋发生至少1种并发症:术中骨折(7.9%)、脱位(6.7%)、假体周围感染(4.5%)、深静脉血栓(3.4%)和晚期假体周围骨折(2.2%)。
- 无组配连接部并发症;8例患者接受再手术,仅3例涉及股骨柄。
- 38例患者(45%)在末次随访前死亡且无已知再手术;27例患者(32%)失访;21例患者(23%)在至少14年随访时存活。
- 19例患者获得完整患者报告结局(随访范围14至18.5年),UCLA活动、VR-12生理、髋关节功能障碍和骨关节炎结局评分-关节置换、Harris髋关节评分疼痛与功能评分均显著改善。
临床怎么用
- 作者认为非骨水泥组配式翻修柄是复杂翻修手术安全可靠的选择。
局限性
- 长期随访的挑战包括患者迁移、不愿长途旅行复查、合并症、高龄和死亡。
- 38例患者(45%)在末次随访前死亡且无已知再手术。
- 27例患者(32%)失访。
- 仅21例患者(23%)在至少14年随访时存活。
- 仅19例患者获得完整患者报告结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As the number of primary total hip arthroplasty (THA) cases increase, so does the demand for revision operations. However, long-term follow-up data for revision THA is lacking. METHODS: A retrospective review was completed of patients who underwent revision THA at a single institution between January 2002 and October 2007 using a cementless modular stem. Patient demographic, clinical, and radiographic data was collected. Preoperative and postoperative patient-reported outcome scores were compared at a minimum of fourteen-year follow-up. RESULTS: Eighty-four patients (89 hips) with a median age of 69 years (range, 28 to 88) at operation were included. Indications for revision included aseptic loosening (84.2%), infection (12.4%), and periprosthetic fracture (3.4%). Twenty-two hips sustained at least 1 complication: intraoperative fracture (7.9%), dislocation (6.7%), prosthetic joint infection (4.5%), deep venous thrombosis (3.4%), and late periprosthetic fracture (2.2%). There were no modular junction complications. Eight patients underwent reoperations; only three involved the stem. Thirty-eight patients (45%) were deceased prior to final follow-up without known reoperations. Twenty-seven patients (32%) were lost to follow-up. Twenty-one patients (23%) were alive at minimum fourteen-year follow-up. Complete patient-reported outcomes were available for nineteen patients (range, 14 to 18.5 years of follow-up). Significant improvement was seen in UCLA activity, VR-12 physical, hip disability and osteoarthritis outcome score, joint replacement., and Harris Hip score pain and function scores. CONCLUSION: Challenges of long-term follow-up include patient migration, an unwillingness to travel for re-examination, medical comorbidities, advanced age, and death. The cementless modular revision stem demonstrated long-term clinical success and remains a safe and reliable option for complex revision operations.
引用
- Valtanen RS, Hwang KL, Amanatullah DF, et al. Revision Hip Arthroplasty Using a Modular, Cementless Femoral Stem: Long-Term Follow-Up. J Arthroplasty. 2022. PMID: 36535440. doi:10.1016/j.arth.2022.12.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。